GWM
SMMT icon

GK Wealth Management’s Summit Therapeutics SMMT Stock Holding History

GK Wealth Management’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.78K Buy
+460
New +$6.88K ﹤0.01% 942

Other funds holding SMMT

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
MHR
Matthew Hamilton Rosenberg $558M AUM 12.28% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM

GK Wealth Management's SMMT Position: Q3 2026 in Review

GK Wealth Management opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 460 shares worth $7.78K. The stake represents ﹤0.01% of the portfolio and ranks #942 among its holdings.

10 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • GK Wealth Management held 460 shares of Summit Therapeutics worth $7.78K as of Q3 2026.
  • Summit Therapeutics was a new GK Wealth Management position in Q3 2026.
  • Summit Therapeutics made up ﹤0.01% of GK Wealth Management's portfolio in Q3 2026, its #942 holding.
  • 10 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.